癌症动态的数学模型,包括治疗和破坏细菌
Anna Geretovszky1, Gergely Röst2
1Bolyai Institute, University of Szeged, 1 Aradi Vértanúk Square, Szeged H-6720, Hungary; Hungarian Centre of Excellence for Molecular Medicine, 9 Budapesti Road, Szeged H-6728, Hungary.
Mathematical biosciences
|September 28, 2025
概括
这项研究模拟了由药物代谢细菌破坏的癌症治疗. 结合化疗和抗生素可能会消灭细菌,改善癌症治疗结果.
科学领域:
- 数学生物学 数学生物学
- 癌症研究 癌症研究
- 药理学 药理学 是一个学科.
背景情况:
- 化疗是癌症治疗的基石.
- 某些细菌可以代谢化疗药物,降低治疗效率.
- 这种相互作用使治疗策略和患者的治疗结果复杂化.
研究的目的:
- 开发一种数学模型,分析化疗中使用药物代谢细菌的癌症动态.
- 研究使用抗生素联合治疗以消除或减轻细菌干扰的潜力.
- 了解癌症或细菌可能存在或被根除的条件.
主要方法:
- 制定了四个微分方程的非线性系统,以建模癌症-细菌-药物相互作用.
- 进行了完整的数学分析来描述所有可能的结果.
- 全球稳定性是使用比较原则来证明的.
- 创建了一个分支图,以可视化基于可控制参数的场景过渡.
主要成果:
- 该模型明确定义了四种不同的结果:癌症灭绝,细菌灭绝,共存或完全根除.
- 稳定性分析证实了这些结果之间的可预测过渡.
- 该研究提供了细菌药物代谢对化疗有效性的影响的见解.
结论:
- 数学建模为理解复杂的癌症治疗动态提供了一个框架.
- 与化疗同时同时使用抗生素是一种可行的策略,可以克服细菌干扰.
- 这些发现对在微生物药物代谢存在的情况下优化癌症治疗有意义.
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Modeling with Differential Equations
7
Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...
7
Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648


